News on Neuroendocrine_Tumors from BioPortfolio.com http://www.BioPortfolio.com Consolidated Neuroendocrine_Tumors news from BioPortfolio.com Wed, 10 Feb 2010 10:37:07 GMT en The Placenta: The Lost Neuroendocrine Organhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012201&HITNO=0&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012201&THISHREF=http://c.moreover.com/click/here.pl%3fz2523288093%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4012201&HITNO=0&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4012201&THISHREF=http://c.moreover.com/click/here.pl%3fz2523288093%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Research and Markets: Neuroendocrine Tumors Drug Pipeline Update 2010http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001805&HITNO=1&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001805&THISHREF=http://c.moreover.com/click/here.pl%3fz2518578048%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001805&HITNO=1&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001805&THISHREF=http://c.moreover.com/click/here.pl%3fz2518578048%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Data Show Progression-Free Survival Advantage With Sutent In Patients With Pancreatic Neuroendocrine Tumorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984026&HITNO=2&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984026&THISHREF=http://c.moreover.com/click/here.pl%3fz2507991254%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3984026&HITNO=2&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3984026&THISHREF=http://c.moreover.com/click/here.pl%3fz2507991254%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Hepatic Metastases From Neuroendocrine Tumors With a 'Thin Slice' Pathological Examination: They are Many Morehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3973979&HITNO=3&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3973979&THISHREF=http://c.moreover.com/click/here.pl%3fz2503224489%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3973979&HITNO=3&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3973979&THISHREF=http://c.moreover.com/click/here.pl%3fz2503224489%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAnnals of Surgery: Pfizer: Data Show Progression-Free Survival Advantage with SutentIn Patients with Pancreatic Neuroendocrine Tumorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967769&HITNO=4&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967769&THISHREF=http://c.moreover.com/click/here.pl%3fz2499911544%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3967769&HITNO=4&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3967769&THISHREF=http://c.moreover.com/click/here.pl%3fz2499911544%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Pheochromocytoma: New pheochromocytoma research has been reported by scientists at GE Healthcarehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3961343&HITNO=5&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3961343&THISHREF=http://c.moreover.com/click/here.pl%3fz2496707010%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3961343&HITNO=5&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3961343&THISHREF=http://c.moreover.com/click/here.pl%3fz2496707010%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Data Show Progression-Free Survival Advantage With Sutent In Patients With Pancreatic Neuroendocrine Tumorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960730&HITNO=6&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960730&THISHREF=http://c.moreover.com/click/here.pl%3fz2496385147%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960730&HITNO=6&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960730&THISHREF=http://c.moreover.com/click/here.pl%3fz2496385147%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmiWeb: Sutent Delays Progression of Pancreatic Neuroendocrine Tumorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960687&HITNO=7&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960687&THISHREF=http://c.moreover.com/click/here.pl%3fz2496369605%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3960687&HITNO=7&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3960687&THISHREF=http://c.moreover.com/click/here.pl%3fz2496369605%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCancer Consultants: Data Show Progression-Free Survival Advantage With Sutent(R) In Patients With Pancreatic Neuroendocrine Tumorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958705&HITNO=8&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958705&THISHREF=http://c.moreover.com/click/here.pl%3fz2495499720%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958705&HITNO=8&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958705&THISHREF=http://c.moreover.com/click/here.pl%3fz2495499720%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Data Show Progression-Free Survival Advantage With Sunitinib in Pancreatic Neuroendocrine Tumorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958474&HITNO=9&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958474&THISHREF=http://c.moreover.com/click/here.pl%3fz2495401062%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3958474&HITNO=9&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3958474&THISHREF=http://c.moreover.com/click/here.pl%3fz2495401062%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPT Community: Medical News: Data Show Progression-Free Survival Advantage With Sutent(R) In Patients With Pancreatic Neuroendocrine Tumorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957123&HITNO=10&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957123&THISHREF=http://c.moreover.com/click/here.pl%3fz2494840952%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3957123&HITNO=10&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3957123&THISHREF=http://c.moreover.com/click/here.pl%3fz2494840952%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: Sunitinib Extends Progression-Free Survival in Patients With Neuroendocrine Tumours of the Pancreas: Presentedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3959213&HITNO=11&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3959213&THISHREF=http://c.moreover.com/click/here.pl%3fz2495680269%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3959213&HITNO=11&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3959213&THISHREF=http://c.moreover.com/click/here.pl%3fz2495680269%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDoctors Guide: Data Show Progression-Free Survival Advantage with Sutent(R) in Patients with Pancreatic Neuroendocrine Tumorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954217&HITNO=12&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954217&THISHREF=http://c.moreover.com/click/here.pl%3fz2492557496%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3954217&HITNO=12&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3954217&THISHREF=http://c.moreover.com/click/here.pl%3fz2492557496%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHealthcare Sales & Marketing Network: ASCO GI: Targeted Agent Slows Neuroendocrine Tumorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3953719&HITNO=13&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3953719&THISHREF=http://c.moreover.com/click/here.pl%3fz2491976330%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3953719&HITNO=13&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3953719&THISHREF=http://c.moreover.com/click/here.pl%3fz2491976330%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedPage Today: Data Show Progression-Free Survival Advantage With Sutent In Patients With Pancreatic Neuroendocrine Tumorshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3951637&HITNO=14&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3951637&THISHREF=http://c.moreover.com/click/here.pl%3fz2490321887%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3951637&HITNO=14&MSIZE=43&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Neuroendocrine_Tumors&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3951637&THISHREF=http://c.moreover.com/click/here.pl%3fz2490321887%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: